Abbott recently received FDA approval for TriClip, a variation of the MitraClip system for the heart's tricuspid valve. Before the FDA said yes to MitraClip in 2013, agency staffers pushed back.

Table 1 highlights key MitraClip dimensions. The system is introduced via femoral venous access and uses trans-septal puncture to enter the left atrium. The system includes the Steerable Guide ...

Abbott Laboratories has announced that its ... than expected for surgery (4.8% for patients treated with the MitraClip system versus 18.2% predicted surgical mortality) and an implant success ...

In severe cases, surgery can repair or replace the valve. If patients are not candidates for surgery, doctors can implant a clothespin-like device called a MitraClip that helps the valve close ...